NCT02048813-D4
Dataset Information
Dataset ID: NCT02048813-D4
PubMed ID (PMID):
Publication Title:
Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib
Description of Dataset:
There are two different submissions (each with one dataset) for PMID 34407545 from ECOG-ACRIN trial E1912. This dataset, NCT02048813-D4, contains updated overall survival and progression-free survival together with baseline marker data. Dataset NCT02048813-D5 contains data on longitudinal measurable residual disease. NCT02048813-D1, -D2, and -D3 contain data from E1912’s primary publication, PMID 31365801. Patients in the NCT02048813-D1, -D2, -D3, -D4, and -D5 data submissions have the same deidentified patient IDs.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT02048813 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®